Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-29 Other | 2026-07-30 4:05 pm | N/A N/A | Yarrow Bioscience Inc. | YARW | RTW Fund Group GP LLC WONG RODERICK 10% Owner | 133,290 | $0 | 9,349,316 (Indirect) | View |
Ownership | 2026-07-30 4:01 pm | N/A N/A | Yarrow Bioscience Inc. | YARW | RTW Fund Group GP LLC WONG RODERICK 10% Owner | 0 | $0 | 9,216,026 (Indirect) | View |
| 2026-07-27 Option Award | 2026-07-29 9:36 pm | N/A 2036-07-27 | Yarrow Bioscience Inc. | YARW | Ashiya Mona Director | 15,435 | $0 | 15,435 (Direct) | View |
| 2026-07-27 Option Award | 2026-07-29 9:33 pm | N/A 2036-07-27 | Yarrow Bioscience Inc. | YARW | Zeronda Tyler Director | 185,798 | $0 | 185,798 (Direct) | View |
Ownership | 2026-07-29 9:26 pm | N/A N/A | Yarrow Bioscience Inc. | YARW | ORBIMED ADVISORS LLC OrbiMed Capital GP X LLC OrbiMed Genesis GP LLC Director | 0 | $0 | 4,934,678 (Indirect) | View |
Ownership | 2026-07-29 9:21 pm | N/A N/A | Yarrow Bioscience Inc. | YARW | Ashiya Mona Director | 0 | $0 | 4,934,678 (Indirect) | View |
Ownership | 2026-07-29 9:20 pm | N/A 2036-04-17 | Yarrow Bioscience Inc. | YARW | White William Richard Director | 0 | $0 | 87,820 (Direct) | View |
Ownership | 2026-07-29 9:17 pm | N/A 2036-04-17 | Yarrow Bioscience Inc. | YARW | Silverman Peter B. Director | 0 | $0 | 87,820 (Direct) | View |
Ownership | 2026-07-29 9:15 pm | N/A 2036-04-17 | Yarrow Bioscience Inc. | YARW | Lundberg Sven Ante Director | 0 | $0 | 175,639 (Direct) | View |
Ownership | 2026-07-29 9:11 pm | N/A 2036-04-17 | Yarrow Bioscience Inc. | YARW | Hoerter Steven L. Director | 0 | $0 | 87,820 (Direct) | View |
Ownership | 2026-07-29 9:08 pm | N/A 2036-01-30 | Yarrow Bioscience Inc. | YARW | Alford Rachael Chief Operating Officer | 0 | $0 | 175,639 (Direct) | View |
Ownership | 2026-07-29 9:05 pm | N/A 2036-01-30 | Yarrow Bioscience Inc. | YARW | Payton Lori Chief Development Officer | 0 | $0 | 175,639 (Direct) | View |
Ownership | 2026-07-29 9:03 pm | N/A 2036-04-17 | Yarrow Bioscience Inc. | YARW | Ryder Steven Chief Medical Officer | 0 | $0 | 228,330 (Direct) | View |
Ownership | 2026-07-29 9:00 pm | N/A 2036-01-30 | Yarrow Bioscience Inc. | YARW | Frey Rebecca Chief Executive Officer | 0 | $0 | 878,194 (Direct) | View |
Ownership | 2026-07-29 4:11 pm | N/A N/A | Yarrow Bioscience Inc. | YARW | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 0 | $0 | 1,233,669 (Indirect) | View |
| 2026-07-23 Tax Withholding | 2026-07-24 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 22,516 | $0.8976 | 74,918 (Direct) | View |
| 2026-07-23 Tax Withholding | 2026-07-24 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER | 15,405 | $0.8976 | 95,944 (Direct) | View |
| 2026-07-23 Tax Withholding | 2026-07-24 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC | 22,516 | $0.8976 | 95,918 (Direct) | View |
| 2026-07-23 Tax Withholding | 2026-07-24 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO | 79,391 | $0.8976 | 347,174 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 8:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 3,464 | $0.6507 | 97,434 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 8:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER | 2,370 | $0.6507 | 111,349 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 8:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC | 3,464 | $0.6507 | 118,434 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 8:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO | 12,214 | $0.6507 | 426,565 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO | 30,791 | $0.31 | 438,779 (Direct) | View |
| 2026-03-31 Tax Withholding | 2026-04-02 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 4,007 | $0.5975 | 99,788 (Direct) | View |
| 2026-03-31 Tax Withholding | 2026-04-02 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER | 2,876 | $0.5975 | 112,363 (Direct) | View |
| 2026-03-31 Tax Withholding | 2026-04-02 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC | 4,007 | $0.5975 | 121,898 (Direct) | View |
| 2026-03-31 Tax Withholding | 2026-04-02 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO | 14,232 | $0.5975 | 401,976 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 08:30 am | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO | 12,684 | $0.5801 | 416,208 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 08:30 am | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 7,858 | $0.5801 | 103,795 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 08:30 am | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER | 2,448 | $0.5801 | 115,239 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 08:30 am | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC | 3,579 | $0.5801 | 125,905 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-15 4:15 pm | N/A 2035-12-11 | VYNE Therapeutics Inc. | VYNE | Little Elisabeth Sandoval Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-15 4:15 pm | N/A 2035-12-11 | VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-15 4:15 pm | N/A 2035-12-11 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-15 4:15 pm | N/A 2035-12-11 | VYNE Therapeutics Inc. | VYNE | BARBARI SHARON Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-02 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 3,420 | $0.335 | 111,653 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-02 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER | 2,453 | $0.335 | 117,687 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-02 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC | 3,581 | $0.335 | 129,484 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-02 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO | 12,676 | $0.335 | 428,892 (Direct) | View |